Your browser doesn't support javascript.
loading
Cardio-oncology: The Role of Big Data.
Mandawat, Anant; Williams, Andrew E; Francis, Sanjeev A.
Afiliação
  • Mandawat A; Division of Cardiovascular Medicine, Duke University School of Medicine, 2301 Erwin Road, Durham, NC 27710, USA.
  • Williams AE; Division of Health Services Research, Center for Outcomes Research and Evaluation, Maine Medical Center Research Institute, 509 Forest Avenue, Suite 200, Portland, MW 04101, USA.
  • Francis SA; Division of Cardiovascular Medicine, Maine Medical Center, 22 Bramhall Street, Portland, ME 04102, USA. Electronic address: SFrancis@mmc.org.
Heart Fail Clin ; 13(2): 403-408, 2017 Apr.
Article em En | MEDLINE | ID: mdl-28279424
ABSTRACT
Despite its challenges, a "big data" approach offers a unique opportunity within the field of cardio-oncology. A pharmacovigilant approach using large data sets can help characterize cardiovascular toxicities of the rapidly expanding armamentarium of targeted therapies. Creating a broad coalition of data sharing can provide insights into the incidence of cardiotoxicity and stimulate research into the underlying mechanisms. Population health necessitates the use of big data and can help inform public health interventions to prevent both cancer and cardiovascular disease. As a relatively new discipline, cardio-oncology is poised to take advantage of big data.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardiopatias / Neoplasias / Antineoplásicos Limite: Humans Idioma: En Revista: Heart Fail Clin Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardiopatias / Neoplasias / Antineoplásicos Limite: Humans Idioma: En Revista: Heart Fail Clin Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos